Early Detection and Diagnostic Efficacy of Advanced Imaging Modalities in Breast Cancer Screening
Downloads
Breast cancer remains one of the leading causes of cancer-related mortality among women globally. Early detection is crucial for improving survival rates and clinical outcomes. Although digital mammography (DM) is the standard screening tool, its diagnostic sensitivity is frequently compromised in dense breast tissues. Methods: A retrospective comparative analysis was performed on a cohort of 500 female patients who underwent both standard Digital Mammography (DM) and Digital Breast Tomosynthesis (DBT). Diagnostic endpoints including sensitivity, specificity, positive predictive value (PPV), and overall diagnostic accuracy were calculated and compared using Chi-square tests. Results: The integration of 3D Digital Breast Tomosynthesis demonstrated a statistically significant improvement in overall diagnostic accuracy, increasing from 72% with standard DM to 84% with DBT (p < 0.05). Sensitivity significantly increased in dense breast tissue classifications, reducing false-positive recall rates by 15.5%. Conclusion: Implementing advanced 3D tomosintez screening protocols vastly enhances diagnostic clarity, diminishes patient anxiety from unneeded recalls, and facilitates early clinical intervention.
[1] H. Sung et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA Cancer J. Clin., vol. 71, no. 3, pp. 209–249, May 2021.
[2] M. Arnold et al., “Current and future burden of breast cancer: Global statistics for 2020 and 2040,” Breast, vol. 66, pp. 15–23, Dec. 2022.
[3] R. L. Siegel, K. D. Miller, N. S. Wagle, and A. Jemal, “Cancer statistics, 2023,” CA Cancer J. Clin., vol. 73, no. 1, pp. 17–48, Jan. 2023.
[4] S. W. Duffy et al., “Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women,” Cancer, vol. 126, no. 13, pp. 2971–2979, Jul. 2020.
[5] E. D. Pisano et al., “Diagnostic performance of digital versus film mammography for breast-cancer screening,” N. Engl. J. Med., vol. 353, no. 17, pp. 1773–1783, Oct. 2005.
[6] N. F. Boyd et al., “Mammographic density and the risk and detection of breast cancer,” N. Engl. J. Med., vol. 356, no. 3, pp. 227–236, Jan. 2007.
[7] M. T. Mandelson et al., “Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers,” J. Natl. Cancer Inst., vol. 92, no. 13, pp. 1081–1087, Jul. 2000.
[8] P. Skaane et al., “Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program,” Radiology, vol. 267, no. 1, pp. 47–56, Apr. 2013.
[9] S. M. Friedewald et al., “Breast cancer screening using tomosynthesis in combination with digital mammography,” JAMA, vol. 311, no. 24, pp. 2499–2507, Jun. 2014.
[10] S. Ciatto et al., “Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): A prospective comparison study,” Lancet Oncol., vol. 14, no. 7, pp. 583–589, Jun. 2013.
[11] E. F. Conant et al., “Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density,” JAMA Oncol., vol. 5, no. 5, pp. 635–642, May 2019.
[12] S. Zackrisson et al., “One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): A prospective, population-based, diagnostic accuracy study,” Lancet Oncol., vol. 19, no. 11, pp. 1493–1503, Nov. 2018.
[13] F. J. Gilbert et al., “Accuracy of digital breast tomosynthesis for depicting breast cancer subgroups in a UK retrospective reading study (TOMMY trial),” Radiology, vol. 277, no. 3, pp. 697–706, Dec. 2015.
[14] D. Bernardi et al., “Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): A population-based prospective study,” Lancet Oncol., vol. 17, no. 8, pp. 1105–1113, Aug. 2016.
[15] American College of Radiology, ACR BI-RADS Atlas: Breast Imaging Reporting and Data System, 5th ed. Reston, VA, USA: Amer. College Radiol., 2013.
[16] P. Dang et al., “Addition of tomosynthesis to conventional digital mammography: Effect on image interpretation time of screening examinations,” Radiology, vol. 270, no. 1, pp. 49–56, Jan. 2014.
[17] K. P. Lowry et al., “Screening performance of digital breast tomosynthesis vs digital mammography in community practice by patient age, screening round, and breast density,” JAMA Netw. Open, vol. 3, no. 7, Art. no. e2011792, Jul. 2020.
[18] J. Brodersen and V. D. Siersma, “Long-term psychosocial consequences of false-positive screening mammography,” Ann. Fam. Med., vol. 11, no. 2, pp. 106–115, Mar. 2013.
[19] D. Sulaymonov and I. Sodiqov, “Comparative evaluation of the diagnostic accuracy of CT and MRI in the detection of liver metastases,” South Aral Region Med. J., vol. 2, no. Maxsus son-2, pp. 514–520, 2026.
[20] US Preventive Services Task Force, “Screening for breast cancer: US Preventive Services Task Force recommendation statement,” JAMA, vol. 331, no. 22, pp. 1918–1930, Jun. 2024.

